Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmologiske - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - isotretinoin - kapsler, bløde - 20 mg

Denmaki - Kidenmaki - SEGES Landbrug & Fødevarer

upl holdings coöperatief u.a. - ethofumesat - suspensionskoncentrat - 500 g/l ethofumesat

Denmaki - Kidenmaki - SEGES Landbrug & Fødevarer

upl holdings coöperatief u.a. - diflufenican - suspensionskoncentrat - 500 g/l diflufenican

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immune sera og immunoglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

pharmaswiss ceska republika s.r.o - pegaptanib - wet macular degeneration - oftalmologiske - macugen er indiceret til behandling af neovaskulær (våd) aldersrelateret makuladegenerering (amd).

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

alternova a/s - diazepam - tabletter - 2 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

alternova a/s - diazepam - tabletter - 5 mg